financetom
Business
financetom
/
Business
/
Update: Oshkosh Shares Jump After Posting Higher-Than-Expected Q4, Issuing Upbeat 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Oshkosh Shares Jump After Posting Higher-Than-Expected Q4, Issuing Upbeat 2025 Guidance
Jan 30, 2025 9:26 AM

12:02 PM EST, 01/30/2025 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.)

Oshkosh (OSK) shares jumped nearly 19% in recent Thursday trading after the company reported Q4 higher-than-expected Q4 results and an upbeat 2025 outlook.

The company earlier reported adjusted earnings of $2.58 per diluted share, up from $2.56 a year earlier.

Analysts polled by FactSet expected $2.17.

Net sales for the quarter ended Dec. 31 were $2.62 billion, compared with $2.47 billion a year earlier.

Analysts surveyed by FactSet expected $2.42 billion.

The company said it expects 2025 adjusted earnings of $11 per diluted share on net sales of around $10.60 billion.

Analysts polled by FactSet expect adjusted EPS of $10.43 on revenue of $10.20 billion.

Oshkosh also said the board increased its quarterly cash dividend to $0.51 per share, payable March 3 to shareholders of record as of Feb. 17.

Price: 113.65, Change: +18.02, Percent Change: +18.84

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hemostemix Amends Manufacturing Agreement With CytoImmune to Accelerate Global Scale-Up
Hemostemix Amends Manufacturing Agreement With CytoImmune to Accelerate Global Scale-Up
Jan 9, 2025
09:50 AM EST, 01/09/2025 (MT Newswires) -- Hemostemix ( HMTXF ) on Thursday said it amended its manufacturing services agreement with CytoImmune Therapeutics to add regulatory consulting and engineering services and align payments made by Hemostemix PR with the policies of both the TSX Venture Exchange and Puerto Rico's ACT 60 Program. The company said CytoImmune's regulatory expert is advising...
Amentum Wins $447 Million Air Forces Central Command Contract
Amentum Wins $447 Million Air Forces Central Command Contract
Jan 9, 2025
09:46 AM EST, 01/09/2025 (MT Newswires) -- Amentum (AMTM) said Thursday it has won a $447 million Air Forces Central Command contract to upgrade prepositioned storage and maintenance services for its Global Prepositioned Materiel Services operations. The move is expected to support efficiency and prolong asset lifecycles, the company said. Price: 21.49, Change: -0.61, Percent Change: -2.76 ...
Informatica Expands Partnership With Google Cloud to Offer Data Governance Product
Informatica Expands Partnership With Google Cloud to Offer Data Governance Product
Jan 9, 2025
10:02 AM EST, 01/09/2025 (MT Newswires) -- Informatica ( INFA ) said Thursday it is expanding its partnership with Alphabet's (GOOG) Google ( GOOG ) via the availability of its cloud data governance and catalog offering on Google Cloud. The product will be available on Google Cloud Marketplace for clients in North America, Europe, the Middle East and Africa, and...
Italy's Meloni defends Musk's political comments amid Starlink talks
Italy's Meloni defends Musk's political comments amid Starlink talks
Jan 9, 2025
* Italy considers Starlink for secure communications * Opposition criticizes potential SpaceX deal, questions Musk's political influence * Meloni defends Musk's right to express his views (Recasts with fuller quotes throughout) By Angelo Amante ROME, Jan 9 (Reuters) - Italian Prime Minister Giorgia Meloni defended Elon Musk's growing involvement in politics on Thursday and said she had never discussed with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved